Jim Simons’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Jim Simons’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-17,205	Closed	-$618K	–	3851
2020 Q4	$618K	Sell	17,205 -5,995	-26%	-$226K	﹤0.01%	2728
2020 Q3	$891K	Sell	23,200 -2,800	-11%	-$101K	﹤0.01%	2579
2020 Q2	$910K	Sell	26,000 -2,000	-7%	-$71.1K	﹤0.01%	2582
2020 Q1	$966K	Buy	28,000 +22	+0.1%	+$766	﹤0.01%	2441
2019 Q4	$929K	Buy	27,978 +17,378	+164%	+$519K	﹤0.01%	2668
2019 Q3	$269K	Buy	+10,600	New	+$240K	﹤0.01%	3064

Other funds holding ZEAL

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Jim Simons's ZEAL Position: Q1 2021 in Review

Jim Simons sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q1 2021, closing a stake of 17,205 shares — an estimated $618K sold.

Jim Simons first reported a position in ZEAL in Q3 2019 and held it in 6 quarters. The position peaked at $966K in Q1 2020. 16 funds tracked by Wall St. Rank hold ZEAL as of Q1 2021.

Jim Simons reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Jim Simons sold 17,205 Zealand Pharma A/S American Depositary Shares shares in Q1 2021, an estimated $618K.
Jim Simons first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2019 and held it in 6 quarters.
Jim Simons's Zealand Pharma A/S American Depositary Shares position peaked at $966K in Q1 2020.
16 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q1 2021.

Based on Renaissance Technologies's 13F filing for Q1 2021, filed 13 May 2021.